References
- Beck , T H , Ciociola , A A , Jones , S E the Ondansetron Study Group . 1993 . Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy . Ann Intern Med , 118 : 407 – 13 .
- Behavioral Health Sciences Division . 1984 . The Lynn Pierson Therapeutic Research Program , New Mexico : Health and Environment Department .
- Behavioral Health Sciences Division . 1983 . The Lynn Pierson Therapeutic Research Program , New Mexico : Health and Environment Department .
- Board of Pharmacy, State of Tennessee . 1983 . Annual Report: Evaluation of marijuana and tetrahydrocannabinol in the treatment of nausea and/or vomiting associated with cancer therapy unresponsive to conventional anti-emetic therapy: Efficacy and toxicity
- Buser , K S , Joss , R A Piquet , D . 1993 . Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorou-racil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study . Ann Oncol , 4 : 475 – 9 .
- Chang , A E , Shiling , D J Stillman , R C . 1979 . Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation . Ann Intern Med , 91 : 819 – 24 .
- Crucitt , M A , Hyman , W Grote , T . 1996 . Efficacy and tolerability of oral ondan-setron versus prochlorperazine in the prevention of emesis associated with cyclo-phosphamide-based chemotherapy and maintenance of health-related quality of life . Clin Ther , 18 ( 4 ) : 778 – 88 .
- Cupissol , D R , Serrou , B and Caubel , M . 1990 . The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis . Eur J Cancer , 26 ( 1 ) : 23 – 7 .
- Department of Social Oncology, Evaluation Unit . 1982 . State of Michigan , Marihuana Therapeutic Research Project .
- Doblin , R and Kleiman , M . 1991 . Marijuana as antiemetic medicine: A survey of oncologists' experiences and attitudes . J Clin Oncol , 9 ( 5 ) : 1314 – 19 .
- Herrstedt , J , Sigsgaard , T , Boesgaard , M , Jensen , T and Dombernowski , P . 1993 . Ondansetron plus metopimazine compared with ondansetron in patients receiving moderately emetogenic chemotherapy . N Engl J Med , 328 ( 15 ) : 1076 – 80 .
- Italian Group for Antiemetic Research . 1995 . Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer . New Engl J Med , 332 ( 1 ) : 1 – 5 .
- Jones , A L , Hill , A S Soukop , M . 1991 . Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy . Lancet , 338 : 483 – 87 .
- Joy , J , Watson , S J and Benson , J A . 1999 . Marijuana as medicine: Assessing the science base , Washington, DC : National Academy Press .
- Kaasa , S , Kval⊘y , S , Dicato , M A the International Emesis Study Group . 1990 . A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: A randomized, double-blind study . Eur J Cancer , 26 ( 3 ) : 311 – 14 .
- Kutner , M H . 1983 . Evaluation of the use of both marijuana and THC in cancer patients for the relief of nausea and vomiting associated with cancer chemotherapy after failure of conventional anti-emetic therapy: Efficacy and toxicity, as prepared for the Composite State Board of Medical Examiners, Georgia Department of Health, by physicians and researchers at Emory University, Atlanta
- Markman , M , Kennedy , A Webster , K . 1996 . Control of carbonplatin-induced emesis with a fixed low dose of granisetron (0.5 mg) plus dexamethasone . Gyne-col Onco , 60 : 435 – 7 .
- Marty , M , Pouillart , P Scholl , S . 1990 . Comparison of the 5-hydroxytryptamine3(serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis . N Engl J Med , 322 ( 12 ) : 816 – 21 .
- Michigan Cancer Foundation, Department of Social Oncology, Evaluation Unit . 1992 . Michigan Department of Public Health Marijuana Therapeutic Research Project, Trial A 1980–81
- Olver , I , Paska , W Depierre , A . 1996 . A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis . Ann Oncol , 7 : 945 – 52 .
- Perez , E A , Navari , R M Kaplan , H G . 1997 . Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis . Support Care Cancer , 5 : 31 – 7 .
- Randall , R C . 1990 . Cancer Treatment & Marijuana Therapy , 225 – 34 . Washington, DC : Galen Press . 1990
- Research Advisory Panel . 1989 . Cannabis Therapeutic Research Program Report to the California Legislature
- Ritter , H L Jr. , Gralla , R J Hall , S W . 1998 . Efficacy of intravenous granisetron to control nausea and vomiting during multiple cycles of cisplatin-based chemotherapy . Cancer Invest , 16 ( 2 ) : 87 – 93 .
- Roila , F , Tonato , M Cognettti , F . 1991 . Prevention of cisplatin-induced emesis: A double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone . J Clin Oncol , 9 ( 4 ) : 675 – 8 .
- Sekine , I , Nishiwaki , Y Kakinuma , R . 1996 . A randomized cross-over trial of granisetron and dexamethasone versus granisetron alone: The role of dexametha-sone on day 1 in the control of cisplatin-induced delayed emesis . Jp J Clin Oncol , 26 ( 3 ) : 164 – 68 .
- Vinciguerra , V , Moore , T and Brennan , E . 1988 . Inhalation marijuana as an antiemetic for cancer chemotherapy . NY State J Med , 88 : 525 – 7 .